DANA BLUMER: Open Payments
NPI 1720700495 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 13 payments from 7 companies in 2025. Trend: 2023 $471 · 2024 $325 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 4 | $182 |
| BETA BIONICS, INC. | 1 | $118 |
| Dexcom, Inc. | 2 | $115 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| Tandem Diabetes Care, Inc. | 1 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $15 |
Products named: Omnipod, iLet Bionic Pancreas, Dexcom G6 Transmitter, TZIELD, t:slim X2 Insulin Pump with Control-IQ, Yorvipath, TWIIST.
Industry payments across CO — which companies pay providers there.
